arrow
J

Joseph Fokam

University of Rome Tor Vergata
H指数:25
被引数:2,193

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Verification of False Reactivity in HIV Rapid Diagnostic Tests and Its Translation Into the Three Tests Algorithm in Cameroon

HIV快速诊断测试中假阳性反应的验证及其在喀麦隆三项测试算法中的应用

2026-09-180
OAAI
Three-year outcomes after genotyping-guided treatment switch in HIV patients with virologic failure in Cameroon: Implications for epidemic control in low-and middle-income countries

基于基因分型指导的治疗转换对喀麦隆HIV病毒学失败患者三年结局的影响:对低收入和中等收入国家疫情控制的启示

2026-08-010
PRE
Updates on the clinical epidemiology of HIV-1 group O strains in Cameroon and potential implications on diagnosis and treatment strategies

关于喀麦隆HIV-1组O毒株的临床流行病学进展及其对诊断和治疗策略的潜在影响

2025-11-190
OAAI
Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options

喀麦隆抗逆转录病毒治疗失败人群中HIV-1对逆转录酶和蛋白酶抑制剂的获得性耐药及其对未来治疗选择的启示

2025-09-300
OAAI
Diagnostic performance of the Hightop Rapid Diagnostic Test for the detection of anti-Treponema pallidum antibodies in Cameroon: a laboratory-based cross-sectional and comparative study

Hightop快速诊断试验检测抗苍白密螺旋体抗体在喀麦隆的诊断性能:一项基于实验室的横断面和比较研究

2025-09-030
OA
Effectiveness of Community-Based Peer-Facilitated Psychological and Social Support Interventions on Improving Mental Health in Cameroonian Adolescents With Perinatal HIV: The IAS-CIPHER-2021/1214-ATE SMAVI Controlled Randomized Trial (November 2021−May 2023)

社区为基础的同伴促进心理和社会支持干预措施对改善患有围产期HIV的喀麦隆青少年心理健康的效果:IAS-CIPHER-2021/1214-ATE SMAVI对照随机试验(2021年11月至2023年5月)

2025-08-250
PRE
HIV-1 Drug Resistance in Children and Implications for Pediatric Treatment Strategies: A Systematic Review and Meta-analysis

HIV-1耐药性在儿童中的表现及其对儿科治疗策略的影响:一项系统评价和荟萃分析

2025-07-011
OAAI
Achieving the global agenda toward HIV cure calls for establishing a research-for-cure academy in West and Central Africa

实现全球艾滋病治愈议程需要在中非和西非建立以治愈为导向的研究学院。

2025-06-270
OAAI
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries
2025-01-060
OAAI
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries
2024-11-290
OAAI
Strengthening and expanding capacities in clinical trials: advancing pandemic prevention, preparedness and response in Africa
2024-10-071
OAAI
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+count assessment for optimized care, the EDCTP READY-study
2024-09-200
OAAI
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study
2024-09-120
OAAI
Strategic HIV Case Findings among Infants at Different Entry Points of Health Facilities in Cameroon: Optimizing the Elimination of Mother-To-Child Transmission in Low- and- Middle-Income Countries
2024-05-100
OAAI
Performance characteristics of INDICAID antigen rapid diagnostic test on SARS-CoV-2 samples during the omicron wave in Cameroon
HELIYON
IF3.6
2024-05-010
OAAI
SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay (SNPsig® SARS-CoV-2 EscapePLEX CE) for the rapid detection of variants of concern in Cameroon

SARS-CoV-2基因组监测和PCR单点突变试验的可靠性 (SNPsig®SARS-CoV-2 EscapePLEX CE),用于快速检测喀麦隆的关注变体

HELIYON
IF3.6
2024-04-010
OAAI
Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-Analysis Toward Pediatric HIV Cure
2024-04-010
PRE
Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness
2024-03-126
OAAI